Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Merck issued patent covering new anticoagulants

Nov. 8, 2000

SBIR grant awarded to MetaPhore for human septic shock study

Nov. 8, 2000

Medicure licenses cardiovascular therapeutics from George Washington University

Nov. 7, 2000

Preparation, activity and use of new cGMP-PDE inhibitors in cardiovascular and other disorders

Nov. 6, 2000

Glaxo Wellcome granted rights to Zambon's ACE/NEP inhibitor

Nov. 3, 2000

Use of vasopeptidase inhibitors in angina pectoris claimed by BMS

Nov. 2, 2000

Human Akt3 and its use in gene therapy disclosed by Aventis

Oct. 31, 2000

RSD-1019: a potential new approach to preventing ischemia-induced arrhythmias

Oct. 27, 2000

Unimed submits NDA for eprosartan/hydrochlorothiazide combination tablet

Oct. 27, 2000

CHEST 2000: anti-TNF MAb improves survival, reduces organ dysfunction in sepsis

Oct. 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...